Foresite Capital Management IV’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Foresite Capital Management IV’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100,000	Closed	-$4.9M	–	20
2018 Q1	$4.9M	Buy	+100,000	New	+$5.2M	2.03%	15

Foresite Capital Management IV's MYOK Position: Q4 2020 in Review

Foresite Capital Management IV sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 126,492 shares — an estimated $17.2M sold.

Foresite Capital Management IV first reported a position in MYOK in Q4 2017 and held it in 12 quarters. The position peaked at $33.3M in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Foresite Capital Management IV reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Foresite Capital Management IV sold 126,492 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $17.2M.
Foresite Capital Management IV first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
Foresite Capital Management IV's MyoKardia, Inc. Common Stock position peaked at $33.3M in Q3 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Foresite Capital Management IV's 13F filing for Q4 2020, filed 16 Feb 2021.